Overview

Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy

Status:
Unknown status
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical safety and efficacy of QingReMoShen Granule to treat idiopathic membranous nephropathy.
Phase:
N/A
Details
Lead Sponsor:
wanglin
Treatments:
Losartan